{"slug":"ozempic-vs-victoza","question":"Ozempic vs Victoza","answer":"Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss (up to 22% body weight reduction) compared to Victoza (up to 6% body weight reduction) in clinical trials.","answer_curated":true,"verdict":"Choose Ozempic if you prioritize maximum weight loss, need less frequent dosing (weekly vs daily), or want a medication approved for both diabetes and obesity treatment. Choose Victoza if you prefer daily injections with faster dose adjustments, require tighter glycemic control with more frequent medication adjustments, or have cost concerns and lack comprehensive insurance coverage.","keyDifferences":[{"label":"Injection Frequency","winner":"a","entityAValue":"Once weekly","entityBValue":"Once daily"},{"label":"Average Weight Loss at Maximum Dose","winner":"a","entityAValue":"Up to 22%","entityBValue":"Up to 6%"},{"label":"FDA Approval for Weight Loss (Type 2 Diabetes)","winner":"a","entityAValue":"Yes (as Wegovy for obesity, Ozempic for diabetes)","entityBValue":"Type 2 diabetes only"},{"label":"Active Ingredient Half-Life","winner":"a","entityAValue":"7 days","entityBValue":"13 hours"},{"label":"Typical Monthly Cost (Without Insurance)","winner":"b","entityAValue":"$900-$1,300","entityBValue":"$800-$1,100"}],"winner":{"slug":"ozempic-semaglutide","name":"Ozempic (Semaglutide)"},"confidence":"high","entities":[{"name":"Ozempic (Semaglutide)","slug":"ozempic-semaglutide","url":"https://www.aversusb.net/entity/ozempic-semaglutide","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/ozempic-semaglutide"},{"name":"Victoza (liraglutide)","slug":"victoza-liraglutide","url":"https://www.aversusb.net/entity/victoza-liraglutide","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/victoza-liraglutide"}],"faqs":[{"question":"Which is more effective for weight loss?","answer":"Ozempic is significantly more effective for weight loss, with clinical trials showing up to 22% body weight reduction compared to Victoza's up to 6%. The STEP trials (Ozempic/Wegovy) demonstrated an average 15.3% weight loss at the 2.4mg dose, while Victoza achieved approximately 5.9% in comparative studies. This 266% greater weight loss is Ozempic's most significant clinical advantage."},{"question":"Is one safer than the other?","answer":"Both medications have excellent safety profiles, but differ in side effect patterns. Ozempic has a slightly higher incidence of gastrointestinal side effects (32% vs 26%), though these typically subside within 4-8 weeks. Victoza has 15+ years of real-world data, but Ozempic has completed major cardiovascular outcomes trials (SUSTAIN-6) showing 26% reduction in major adverse cardiovascular events. Neither is inherently safer; Victoza offers more experience while Ozempic offers stronger cardiovascular evidence."},{"question":"How much do these medications cost?","answer":"Without insurance, Ozempic costs $900-$1,300 per month while Victoza costs $800-$1,100 per month. However, most insurance plans cover both for type 2 diabetes. GLP-1 drugs for weight loss (Wegovy/Saxenda) are less commonly covered. Many manufacturers offer copay assistance cards bringing out-of-pocket costs to $0-$250/month for insured patients. Uninsured patients should ask about patient assistance programs that can reduce costs by 50-75%."}],"attribution":{"source":"A Versus B","url":"https://www.aversusb.net/compare/ozempic-vs-victoza","license":"CC BY 4.0","citationFormat":"According to A Versus B (https://www.aversusb.net/compare/ozempic-vs-victoza), Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss (up to 22% body weight redu","dateModified":"2026-06-24T19:23:18.387Z"},"relatedQuestionsUrl":"https://www.aversusb.net/api/faq/ozempic-vs-victoza","relatedComparisonsUrl":"https://www.aversusb.net/api/v1/related/ozempic-vs-victoza","knowledgeGraphUrl":"https://www.aversusb.net/api/knowledge-graph/ozempic-vs-victoza","claimReviewSchema":{"@context":"https://schema.org","@type":"ClaimReview","@id":"https://www.aversusb.net/compare/ozempic-vs-victoza#claimreview","url":"https://www.aversusb.net/compare/ozempic-vs-victoza","inLanguage":"en-US","isAccessibleForFree":true,"conditionsOfAccess":"Free","claimReviewed":"Ozempic vs Victoza","reviewBody":"Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss (up to 22% body weight reduction) compared to Victoza (up to 6% body weight reduction) in clinical trials.","datePublished":"2026-06-24T19:23:17.222Z","dateModified":"2026-06-24T19:23:18.387Z","reviewRating":{"@type":"Rating","ratingValue":5,"worstRating":1,"bestRating":5,"alternateName":"High Confidence"},"author":{"@type":"Organization","@id":"https://www.aversusb.net/#organization","name":"A Versus B","url":"https://www.aversusb.net"},"itemReviewed":{"@type":"WebPage","@id":"https://www.aversusb.net/compare/ozempic-vs-victoza","url":"https://www.aversusb.net/compare/ozempic-vs-victoza","name":"Ozempic vs Victoza","inLanguage":"en-US"}}}